Drug cuts COVID-19 deaths in hospitalized patients by two-thirds: study  Sports Grind EntertainmentView Full coverage on Google News
An arthritis drug may cut deaths in hospitalized COVID-19 patients by about two thirds among those suffering from moderate or severe cases of the virus, according to a new study. Called baricitinib, and marketed under the brand name Olumiant, the medication has been touted by its British company as a possible game changer in the […]

Drug cuts COVID-19 deaths in hospitalized patients by two-thirds: study | Sports Grind Entertainment

The daily pill, first earmarked as a potential Covid game-changer by a British firm, reduces deaths by 71 per cent in those with moderate or severe illness, researchers say.The daily pill, first earmarked as a potential Covid game-changer by a British firm, reduces deaths by 71 per cent in those with moderate or severe illness, researchers say.

Arthritis drug 'cuts elderly Covid-19 deaths by two-thirds', say researchers | Daily Mail Online

In a major win against the Covid-19 researchers have identified that an Arthritis drug can help in reducing the mortality rate in elderly people by 71%. As per the findings, a daily pill of baricitinib along with standard care can reduce the deaths by 71% in Covid-19 patients with moderate or severe...In a major win against the Covid-19 researchers have identified that an Arthritis drug can help in reducing the mortality rate in elderly people by 71%. As per the findings, a daily pill of baricitinib along with standard care can reduce the deaths by 71% in Covid-19 patients with moderate or severe infection.

Arthritis drug can reduce mortality rate in Covid-19 patients by 71%: Study - world news - Hindustan Times

Called baricitinib, and marketed under the brand name Olumiant, the medication has been touted by its British company as a possible game changer in the fight against COVID-19, the Daily Mail reported.An arthritis drug may cut deaths in hospitalized COVID-19 patients by about two thirds among those suffering from moderate or severe cases of the virus, according to a new study. Called baricitinib,

Drug cuts COVID-19 deaths in hospitalized patients by two-thirds: study